Table 2 Histologic diagnosis
1994 to 2001 | 2002 to 2006 | 2007 to 2012 | |
|---|---|---|---|
Malignoma | |||
Ductal adenocarcinoma | 81 (22.3%) | 108 (35.4%) | 191 (42.3%) |
Distal bile duct cancer | 13 (3.6%) | 29 (9.5%) | 15 (3.3%) |
Ampullary carcinoma | 25 (6.9%) | 29 (9.5%) | 34 (7.5%) |
Duodenal carcinoma | 2 (0.6%) | 9 (3.0%) | 4 (0.9%) |
Pancreatic neuroendocrine tumor | 6 (1.7%) | 13 (4.3%) | 29 (4.3%) |
Metastases | 4 (1.1%) | 5 (1.6%) | 9 (2.0%) |
Benign tumors | |||
IPMN | 0 (0%) | 7 (2.3%) | 35 (7.7%) |
Chronic pancreatitis | 204 (56.2%) | 83 (27.2%) | 78 (17.3%) |
Others | 28 (7.7%) | 22 (7.2%) | 57 (12.6%) |